Showing results (1141-1150 of 1,468) with videos related to

Sort By:
Pageof 147
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 2, 2023
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17β-FluoroestradiolGary A Ulaner, David A Mankoff, Amy S Clark, et al.
Breast Cancer Research : BCR|September 11, 2020
A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imagingAgnes Jager, Elisabeth G E de Vries, C Willemien Menke-van der Houven van Oordt, et al.
Acta Neuropathologica|August 24, 2014
Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosisMark R Mizee, Philip G Nijland, Susanne M A van der Pol, et al.
Brain : a Journal of Neurology|November 22, 2018
Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathyAnanya Chakraborty, Alwin Kamermans, Bert van Het Hof, et al.
Cell Death & Disease|February 6, 2019
Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiologyClaudio Derada Troletti, Ruud D Fontijn, Elizabeth Gowing, et al.
Plos One|April 5, 2019
The P4-ATPase ATP9A is a novel determinant of exosome releaseJyoti Naik, Chi M Hau, Lysbeth Ten Bloemendaal, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphismsRobert A M Op den Buijsch, Maarten H L Christiaans, Leo M L Stolk, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Modulation of death receptor pathways in oncologyE G E de Vries, T Timmer, N H Mulder, et al.
Clinical Obesity|May 25, 2022
General population normative scores for interpreting the BODY-QFarima Dalaei, Claire E E de Vries, Lotte Poulsen, et al.
Molecular Imaging|May 15, 2014
(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatmentSietske B M Gaykema, Johan R de Jong, Patrick J Perik, et al.
Pageof 147